en
Fespixon® is not approved by the U.S. FDA. This website is intended for international healthcare professionals outside the U.S. only.
Contact Us
en
Fespixon® is not approved by the U.S. FDA. This website is intended for international healthcare professionals outside the U.S. only.
Contact Us

Knowledge

Education
2025-04-13

Diabetes and Chronic Wounds

Chronic wounds are a common complication among diabetic patients, primarily because the wounds remain in the inflammatory stage for an extended period.
Read More
2025-05-19

Daily Care and Prevention of Diabetes

Starting with daily health care, maintaining the body's optimal condition at all times can slow down the progression of diabetes.
Read More
2025-05-27

Global Status and Challenges of Diabetic Foot Ulcers (DFU): A Growing Public Health Concern

There are over 500 million people with diabetes globally, and approximately 18 million are at risk of developing 'Diabetic Foot Ulcers' each year. Remarkably, up to 34% of individuals with diabetes may experience DFU during their lifetime. Remarkably, up to 34% of individuals with diabetes may experience DFU during their lifetime.
Read More
1 2 3 4
Training